Everspan organizes published research for informational purposes only. This is not medical advice. Consult a healthcare provider before starting any intervention.
Trending
Back to Atlas
T2· OptimizationD· TheoreticalSupplementSupplements
Hormonal

Fadogia Agrestis

West African plant extract studied for potential testosterone-supporting effects, but human evidence remains extremely limited.

Human Trials

0

0 participants

Risk Level

Medium Risk

Monthly Cost

$25$60 /month

Varies significantly by extract concentration and brand

Quick Facts

Category
Supplement
Research Field
Supplements
Evidence Grade
D – Theoretical
Risk Level
Medium
Monthly Cost
$25 – $60
Human Trials
0

Research Velocity

Emerging Field
2 publications in the last 12 months · limited publications – early-stage research

Mechanism of Action

Research indicates that Fadogia agrestis may influence testosterone production through stimulation of Leydig cells in the testes, based on animal studies. The plant's bioactive compounds appear to enhance luteinizing hormone signaling pathways, though the exact mechanisms remain poorly understood and are extrapolated primarily from rodent models.

Overview

Fadogia agrestis is a West African shrub traditionally used in folk medicine for enhancing male vitality and libido. Research on this plant remains extremely limited, with virtually all available data derived from small animal studies conducted primarily in the early 2000s. These preliminary investigations suggested potential effects on testosterone levels in male rats, leading to interest in the supplement community despite the absence of human clinical trials.

The current evidence base consists almost entirely of animal research, with no published human studies examining safety or efficacy. Animal studies have indicated possible increases in testosterone levels and related parameters, but also noted potential kidney toxicity at higher doses. The lack of human data makes it impossible to determine appropriate dosing, safety profiles, or actual effectiveness in humans. Additionally, the quality and standardization of commercial Fadogia agrestis extracts varies significantly, as there are no established manufacturing standards or regulatory oversight for this supplement.

Given the complete absence of human clinical data and potential safety concerns identified in animal studies, individuals considering this supplement should be aware that its effects, safety profile, and optimal dosing in humans remain entirely unknown. The supplement's popularity appears to be based largely on anecdotal reports and extrapolation from limited animal research rather than robust scientific evidence.

Known Interactions

  • May potentiate effects of testosterone replacement therapy
  • Potential interactions with blood pressure medications due to observed cardiovascular effects in animal studies
  • May interfere with hormone-sensitive medications

Legal Status by Country

📍

Your country (United States)

Sold as dietary supplement, no FDA approval

Unregulated
✈️

Available without prescription in:

Australia, Brazil, Canada, China, Colombia, Germany, India, Israel, Japan, Mexico, Netherlands, Panama, Russia, South Korea, Switzerland, Thailand, Turkey, UAE, United Kingdom, United States

Australia
Unregulated
✈️Brazil
Unregulated
Canada
Unregulated
China
Unregulated
✈️Colombia
Unregulated
Germany
Unregulated
✈️India
Unregulated
✈️Israel
Unregulated
Japan
Unregulated
✈️Mexico
Unregulated
Netherlands
Unregulated
✈️Panama
Unregulated
Russia
Unregulated
✈️South Korea
Unregulated
Switzerland
Unregulated
✈️Thailand
Unregulated
✈️Turkey
Unregulated
✈️UAE
Unregulated
United Kingdom
Unregulated
📍United States
Unregulated

📍 = your selected country · ✈️ = medical tourism destination · Always verify current local regulations before travel.

Key Research

Last verified: 2026-03-19